BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6349209)

  • 1. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y; Chi Z
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of peptide C determination in diabetes].
    Halaby G; Karam J; Jambart S; Aydenian H; Zankoul R; Gannagé MH
    J Med Liban; 1989; 38(1):29-34. PubMed ID: 2519329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
    Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
    Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
    Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
    Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood serum content of C-peptide and insulin in obese children].
    Zubovskiĭ GA; Smirnova GI; Leonova LN
    Vopr Okhr Materin Det; 1979 Oct; 24(10):33-8. PubMed ID: 516548
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of C-peptide in the classification of diabetes mellitus.
    Wright-Pascoe R; Mills J; Choo-Kang E; Morrison EY
    West Indian Med J; 2000 Jun; 49(2):138-42. PubMed ID: 10948853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C-peptide levels in secondary sulfonylurea resistant diabetics].
    Balázsi I; Takács J; Hargitai G
    Orv Hetil; 1993 Dec; 134(52):2859-62. PubMed ID: 8272351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.